rhGH
rhGH is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome
Vesiculogenesis in Children With GH Deficiency (VESCIGHTP)
A Trial of YPEG-rhGH in Children With Short Stature
Long-Acting Growth Hormone in Children Compared to Daily rhGH
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
Clinical Trials (7)
Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome
Vesiculogenesis in Children With GH Deficiency (VESCIGHTP)
A Trial of YPEG-rhGH in Children With Short Stature
Long-Acting Growth Hormone in Children Compared to Daily rhGH
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
Mechanism of Growth Hormone Effects on Adipose Tissue
A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7